IPC분류정보
| 국가/구분 |
United States(US) Patent
등록
|
| 국제특허분류(IPC7판) |
|
| 출원번호 |
US-0859886
(2001-05-16)
|
|
발명자
/ 주소 |
- Finch, Charles D.
- Marad, Paul F.
- Wang, John
- Brugger, James M.
|
| 출원인 / 주소 |
|
| 대리인 / 주소 |
Townsend and Townsend and Crew LLP
|
| 인용정보 |
피인용 횟수 :
26 인용 특허 :
53 |
초록
▼
Implanted catheters are locked with a solution comprising a lower alcohol, typically ethanol, propanol, or butanol, in a range from 1% to 99% by volume, and an additive in a range from 1% to 99% by volume, the additive comprising an anti-microbial, typically taurolidine or triclosan, or an anti-coag
Implanted catheters are locked with a solution comprising a lower alcohol, typically ethanol, propanol, or butanol, in a range from 1% to 99% by volume, and an additive in a range from 1% to 99% by volume, the additive comprising an anti-microbial, typically taurolidine or triclosan, or an anti-coagulant, typically riboflavin, sodium citrate, ethylene diamine tetraacetic acid, or citric acid. The use of an alcohol and additive solution can effectively reduce fouling of the catheter, particularly clotting and thrombus in intravascular catheters, as well as eradicate existing infections and/or reduce the risk of potential infections. Existing infections and/or potential infections can be further reduced by employing a catheter body which permits an anti-microbial solution to penetrate into the catheter body and preferably through the catheter into tissue surrounding the implanted catheter.
대표청구항
▼
Implanted catheters are locked with a solution comprising a lower alcohol, typically ethanol, propanol, or butanol, in a range from 1% to 99% by volume, and an additive in a range from 1% to 99% by volume, the additive comprising an anti-microbial, typically taurolidine or triclosan, or an anti-coag
Implanted catheters are locked with a solution comprising a lower alcohol, typically ethanol, propanol, or butanol, in a range from 1% to 99% by volume, and an additive in a range from 1% to 99% by volume, the additive comprising an anti-microbial, typically taurolidine or triclosan, or an anti-coagulant, typically riboflavin, sodium citrate, ethylene diamine tetraacetic acid, or citric acid. The use of an alcohol and additive solution can effectively reduce fouling of the catheter, particularly clotting and thrombus in intravascular catheters, as well as eradicate existing infections and/or reduce the risk of potential infections. Existing infections and/or potential infections can be further reduced by employing a catheter body which permits an anti-microbial solution to penetrate into the catheter body and preferably through the catheter into tissue surrounding the implanted catheter. Sheldon; US-2764149, 19560900, Sheldon; US-2877368, 19590300, Sheldon; US-3021834, 19620200, Sheldon; US-3417745, 19681200, Sheldon; US-3437747, 19690400, Sheldon; US-3499107, 19700300, Sheldon; US-3538916, 19701100, Wiles; US-3556085, 19710100, Takahashi; US-3762416, 19731000, Moss et al.; US-3809095, 19740500, Cimber; US-3915169, 19751000, McGuire; US-3961621, 19760600, Northeved; US-4137920, 19790200, Bonnet, 606/171; US-4210146, 19800700, Banko; US-4220155, 19800900, Kimberling et al.; US-4254762, 19810300, Yoon; US-4256119, 19810300, Gauthier; US-4269192, 19810500, Matsuo; US-4345589, 19820800, Hiltebrandt; US-4411653, 19831000, Razi; US-4461305, 19840700, Cibley; US-4516575, 19850500, Gerhard et al.; US-4535773, 19850800, Yoon; US-4539976, 19850900, Sharpe; US-4559041, 19851200, Razi; US-4566438, 19860100, Liese et al.; US-4570632, 19860200, Woods; US-4653475, 19870300, Seike et al.; US-4667684, 19870500, Leigh; US-4723545, 19880200, Nixon; US-4733671, 19880300, Mehl; US-4790312, 19881200, Capuano, Sr. et al.; US-4865029, 19890900, Pankratov et al.; US-4904246, 19900200, Atkinson; US-4957112, 19900900, Yokoi et al.; US-4962770, 19901000, Agee et al.; US-4976269, 19901200, Mehl; US-4991600, 19910200, Taylor; US-5066288, 19911100, Deneiga et al.; US-5089000, 19920200, Agee et al.; US-5092872, 19920300, Segalowitz; US-5104382, 19920400, Brinkerhoff et al.; US-5116353, 19920500, Green; US-5146921, 19920900, Terwilliger et al.; US-5152754, 19921000, Plyley et al.; US-5158552, 19921000, Borgia et al.; US-5159920, 19921100, Condon et al.; US-5176695, 19930100, Dulebohn; US-5183053, 19930200, Yeh et al.; US-5186178, 19930200, Yeh et al.; US-5250068, 19931000, Ideguchi et al.; US-5271380, 19931200, Riek et al.; US-5275583, 19940100, Crainich; US-5290276, 19940300, Sewell, Jr., 606/015; US-5314417, 19940500, Stephens et al.; US-5334150, 19940800, Kaali, 604/164.08; US-5354302, 19941000, Ko; US-5372588, 19941200, Farley et al.; US-5385572, 19950100, Nobles et al., 606/185; US-5406940, 19950400, Melzer et al.; US-5431151, 19950700, Riek et al., 600/104; US-5467762, 19951100, Sauer et al., 600/114
※ AI-Helper는 부적절한 답변을 할 수 있습니다.